Research centers
Washington, DC
An integrated oncology research hub advancing next-generation cancer therapies.
Located just north of Washington, the Axion site opened in 1998 and unites office, laboratory, and manufacturing spaces across the 500,000 square foot campus. The site is focused on revolutionizing cancer treatment, with experts in antibody discovery, chemistry, biology, immunology, antibody drug conjugate (ADC) design, and translational pathology helping to pioneer innovative cancer therapies.
Areas of focus
- Antibody discovery
- Chemistry & biology
- Immunology
- ADC design
- Translational pathology
Integrated development
The expansive R&D facilities combine with multi-product manufacturing capabilities to more seamlessly integrate production and process development across the site. The Washington site is one of Axion's newest major R&D hubs following the acquisition of Seagen in 2023.